Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1524

1.
2.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S.

Arch Neurol. 2002 Oct;59(10):1553-62.

PMID:
12374492
3.

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).

Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.

Sleep Med. 2003 Jan;4(1):7-12.

PMID:
14592354
4.

[Symptomatic hypersomnia due to orexin deficiency in hypothalamic lesions].

Kanbayashi T, Arii J, Kubota H, Yano T, Kashiwagi M, Yoshikawa S, Tohyama J, Sawaishi Y.

No To Hattatsu. 2006 Sep;38(5):340-5. Japanese.

PMID:
16986734
5.

The clinical spectrum of narcolepsy with cataplexy: a reappraisal.

Sturzenegger C, Bassetti CL.

J Sleep Res. 2004 Dec;13(4):395-406.

6.

Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.

Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH.

Sleep. 2002 Nov 1;25(7):733-6.

PMID:
12405608
7.

Narcolepsy and the hypocretins.

Wurtman RJ.

Metabolism. 2006 Oct;55(10 Suppl 2):S36-9. Review.

PMID:
16979425
8.

Emerging treatments for narcolepsy and its related disorders.

Nishino S, Okuro M.

Expert Opin Emerg Drugs. 2010 Mar;15(1):139-58. doi: 10.1517/14728210903559852. Review.

PMID:
20166851
9.

Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness.

Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E.

Sleep. 2003 May 1;26(3):287-90.

PMID:
12749547
10.

Narcolepsy: pathophysiology and pharmacology.

Nishino S.

J Clin Psychiatry. 2007;68 Suppl 13:9-15. Review.

11.

The pathophysiologic basis of secondary narcolepsy and hypersomnia.

Kanbayashi T, Sagawa Y, Takemura F, Ito SU, Tsutsui K, Hishikawa Y, Nishino S.

Curr Neurol Neurosci Rep. 2011 Apr;11(2):235-41. doi: 10.1007/s11910-011-0178-y.

PMID:
21298561
12.

CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.

Kanbayashi T, Inoue Y, Chiba S, Aizawa R, Saito Y, Tsukamoto H, Fujii Y, Nishino S, Shimizu T.

J Sleep Res. 2002 Mar;11(1):91-3.

13.

Narcolepsy in Parkinson's disease.

Haq IZ, Naidu Y, Reddy P, Chaudhuri KR.

Expert Rev Neurother. 2010 Jun;10(6):879-84. doi: 10.1586/ern.10.56. Review.

PMID:
20518604
14.

[Narcolepsy with cataplexy].

Dauvilliers Y, Arnulf I.

Rev Neurol (Paris). 2008 Aug-Sep;164(8-9):634-45. doi: 10.1016/j.neurol.2007.08.012. Epub 2008 Mar 4. Review. French.

PMID:
18805301
15.

Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.

Kubota H, Kanbayashi T, Tanabe Y, Ito M, Takanashi J, Kohno Y, Shimizu T.

Sleep. 2003 Aug 1;26(5):555-7.

PMID:
12938807
16.

Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.

Gerashchenko D, Blanco-Centurion C, Greco MA, Shiromani PJ.

Neuroscience. 2003;116(1):223-35.

PMID:
12535955
17.

Sleep, sleep disorders and hypocretin (orexin).

Mignot E.

Sleep Med. 2004 Jun;5 Suppl 1:S2-8. Review. Erratum in: Sleep Med. 2004 Sep;5(5):515.

PMID:
15301991
18.

[Wake disorders. I. Primary wake disorders].

Billiard M, Carlander B.

Rev Neurol (Paris). 1998 Feb;154(2):111-29. Review. French.

PMID:
9773032
19.

Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.

Knudsen S, Gammeltoft S, Jennum PJ.

Brain. 2010 Feb;133(Pt 2):568-79. doi: 10.1093/brain/awp320. Epub 2010 Feb 3.

PMID:
20129934
20.

The hypocretin/orexin system in health and disease.

Nishino S.

Biol Psychiatry. 2003 Jul 15;54(2):87-95. Review. Erratum in: Biol Psychiatry. 2003 Jul 15;54(2):175.

PMID:
12873797

Supplemental Content

Support Center